Can a phone app help young people with diabetes control blood sugar?
NCT ID NCT06375460
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a smartphone app that shows real-time blood sugar and activity data can help adolescents and young adults with type 2 diabetes improve their glucose control. Participants use a continuous glucose monitor and Fitbit, and some receive prompts to reflect on their data and plan diet or exercise. The trial lasts 90 days with an additional 90-day follow-up, and includes 100 participants.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Focused App Prompt (behavioral intervention via smartphone app)
What this could lead to
If it works, this could point toward a simple, app-based way to help young people with type 2 diabetes better manage their blood sugar day-to-day.
What could go wrong
This is a small, early-stage trial (100 participants) testing a behavioral tool, not a drug. The app may not lead to lasting improvements, and results may not apply to everyone with type 2 diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, 15224, United States